Track Your Future Recoveries Withsnaptrade iconConnect Account

Reata Pharmaceuticals Settlement
(NASDAQ: RETA)
Settlement

Claim Deadline: April 24, 2024

Settlement Fund: $45,000,000

Settlement Class

All persons or entities who purchased or otherwise acquired the publicly traded common stock of Reata between November 14, 2016 and December 8, 2021, inclusive, including all persons or entities who purchased or otherwise acquired Reata common stock pursuant and/or traceable to Reata’s 2019 Offering and/or 2020 Offering.

Important Documents

Settlement Notice

Proof Of Claim

Settlement Status

Preliminarily Approved

Class Period

November 14, 2016 - December 08, 2021

Settlement Hearing Date

March 29, 2024

Opt-Out Deadline

March 08, 2024

Settlement Website

https://www.reatasecuritieslitigation.com/

Claims Admin

Doyle v. Reata Pharmaceuticals, Inc.c/o EpiqP.O. Box 5566Portland, OR 97228-5566Toll Free Number: 1-877-664-7398info@ReataSecuritiesLitigation.com

Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.